This site is intended for U.S. audiences only.
IDHIFA® is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children.
IDHIFA® is an oral medication that you can take at home
To learn more about serious side effects and how they may affect you, speak with your healthcare team or refer to the Medication Guide.
Access downloadable PDFs and additional information and tools for your treatment and disease.